Compare · NSYS vs TMO
NSYS vs TMO
Side-by-side comparison of Nortech Systems Incorporated (NSYS) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- NSYS operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $174.52B, about 3831.4x NSYS ($45.6M).
- Over the past year, NSYS is up 55.2% and TMO is up 14.9% - NSYS leads by 40.2 points.
- TMO has been more active in the news (17 items in the past 4 weeks vs 2 for NSYS).
- TMO has more recent analyst coverage (25 ratings vs 0 for NSYS).
- Company
- Nortech Systems Incorporated
- Thermo Fisher Scientific Inc
- Price
- $16.68-1.30%
- $469.56-0.67%
- Market cap
- $45.6M
- $174.52B
- 1M return
- +32.91%
- -1.03%
- 1Y return
- +55.16%
- +14.92%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 2
- 17
- Recent ratings
- 0
- 25
Nortech Systems Incorporated
Nortech Systems Incorporated operates as an electronic manufacturing services company in the United States, Mexico, and China. It offers a range of value added engineering, technical and manufacturing, and support services, including project management, designing, testing, prototyping, supply chain management, and post-market services. The company also provides manufacturing and engineering services for medical devices, printed circuit board assemblies, wire and cable assemblies, and higher level electromechanical assemblies. In addition, it offers repair services. The company serves original equipment manufacturers in the aerospace and defense, medical, and industrial markets through business development teams and independent manufacturers' representatives. Nortech Systems Incorporated was founded in 1990 and is headquartered in Maple Grove, Minnesota.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest NSYS
- SEC Form S-8 filed by Nortech Systems Incorporated
- SEC Form SD filed by Nortech Systems Incorporated
- Nortech Systems Incorporated filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Nortech Systems Reports First Quarter Results
- Nortech Systems Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by Nortech Systems Incorporated
- Nortech Systems Incorporated to Report First Quarter 2026 Financial Results and Hold a Conference Call on May 14, 2026
- Amendment: SEC Form 10-K/A filed by Nortech Systems Incorporated
- Nortech Systems Launches Power over Fiber Technology Platform for EMI-Sensitive Applications
- SEC Form DEF 14A filed by Nortech Systems Incorporated
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)